Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123253) titled 'Prospective, multicenter, cohort study on the improvement of chronic hepatitis B with fatty liver by semaglutide (Novonorm)' on April 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University
Condition:
HBV infection complicated with MAFLD
Intervention:
Observation group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-06
Target Sample Size: Observation group:100;Control group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=315861...